Caprock Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,207	Closed	-$225K	–	489
2020 Q4	$225K	Buy	+4,207	New	+$225K	0.03%	411
2020 Q3	–	Sell	-4,147	Closed	-$201K	–	408
2020 Q2	$201K	Buy	+4,147	New	+$201K	0.03%	367